Home › High Blood Pressure › Kansas › Topeka
High Blood Pressure clinical trials in Topeka, KS
3 studies for High Blood Pressure are looking for participants at sites in and around Topeka (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
RecruitingPhase 3
- Cotton O'Neil Diabetes & Endocrinology Center, Topeka
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
RecruitingPhase 3
- Cotton O'Neil Clinical Research Center, Topeka
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
RecruitingPhase 3
- Clinical Trial Site, Topeka
About High Blood Pressure
High blood pressure (hypertension) develops when blood flows through arteries at higher than normal pressures. It increases the risk for heart disease and stroke.
More about High Blood Pressure on MedlinePlus
High Blood Pressure trials in other cities
- Chicago, IL21 studies
- Boston, MA21 studies
- Dallas, TX16 studies
- Nashville, TN13 studies
- Birmingham, AL11 studies
- Houston, TX11 studies
- Durham, NC10 studies
- Atlanta, GA10 studies
- Tucson, AZ10 studies
- New York City, NY9 studies
- Miami, FL9 studies
- Baltimore, MD9 studies
Other studies in Topeka
- Steatotic Liver Disease7 studies
- Overweight7 studies
- Prostate Cancer7 studies
- Non-Small Cell Lung Cancer7 studies
- Obesity6 studies
- Breast Cancer6 studies
- Lung Cancer6 studies
- Crohn's Disease6 studies
- Type 2 Diabetes5 studies
- Cardiovascular Disease5 studies
- Bladder Cancer4 studies
- Esophageal Cancer4 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.